Mark McKinlay

Mark is Director for the Center for Vaccine Equity at the Task Force for Global Health in Decatur, GA. Mark also serves as Director of The Task Force’s Polio Eradication program. Prior to joining the Task Force, Mark was co-founder, Chief Scientific Officer and Senior Vice President for Research and Development of TetraLogic Pharmaceuticals, co-founder and Vice President of R&D of ViroPharma Incorporated (acquired in 2014 by Shire) and Senior Director, Virology and Oncopharmacology in the research group at Sterling Drug where he discovered a novel class of antipicornavirus agents presently being developed to treat poliovirus infections in immune deficient poliovirus excreters.